Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Frank Scappaticci
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM)
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Correction: A Phase II Trial of 1st-Line Modified-Folfoxiri Plus Bevacizumab Treatment for Metastatic Colorectal Cancer Harboring RAS Mutation: JACCRO CC-11
Oncotarget
Oncology
A Phase 2 Randomised Study of Veliparib Plus FOLFIRI±bevacizumab Versus Placebo Plus FOLFIRI±bevacizumab in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-Line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
A Phase II Trial of Erlotinib in Combination With Bevacizumab in Patients With Metastatic Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis
Oncologist
Cancer Research
Medicine
Oncology
Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
P1.01-40 Randomized Phase II Study of Docetaxel Plus Bevacizumab or Pemetrexed Plus Bevacizumab for Elderly PTS With Untreated Advanced NSCLC: TORG1323
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Critical Appraisal of Bevacizumab in the Treatment of Metastatic Colorectal Cancer
OncoTargets and Therapy
Oncology
Pharmacology
